GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+12.2%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$276M
AUM Growth
+$276M
(-4%)
Cap. Flow
-$42.3M
Cap. Flow
% of AUM
-15.35%
Top 10 Holdings %
Top 10 Hldgs %
40.38%
Holding
70
New
9
Increased
16
Reduced
22
Closed
18
Top Buys
| 1 |
Novo Nordisk
NVO
|
$13.1M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$9.25M |
| 3 |
Sarepta Therapeutics
SRPT
|
$8.12M |
| 4 |
Janux Therapeutics
JANX
|
$6.36M |
| 5 |
Edgewise Therapeutics
EWTX
|
$5.2M |
Top Sells
| 1 |
Biohaven
BHVN
|
$17M |
| 2 |
Viridian Therapeutics
VRDN
|
$11.7M |
| 3 |
MoonLake Immunotherapeutics
MLTX
|
$8.65M |
| 4 |
Vaxcyte
PCVX
|
$8M |
| 5 |
Soleno Therapeutics
SLNO
|
$7.57M |
Sector Composition
| 1 | Healthcare | 100% |
